---
figid: PMC8948490__jbm-2022-29-1-1f1
figtitle: Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Pathway
  in Osteoblasts
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Danio rerio
- Mouse mammary tumor virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC8948490
filename: jbm-2022-29-1-1f1.jpg
figlink: /pmc/articles/PMC8948490/figure/f1-jbm-2022-29-1-1/
number: F1
caption: A diagram of extracellular signal-regulated kinase (ERK) mitogen-activated
  protein kinase (MAPK) signaling pathways in osteoblasts. Noteworthy inhibitors,
  including both clinical drugs and tool compounds, are indicated. NF1, neurofibromatosis
  type 1; GDP, guanosine diphosphate; GTP, guanosine triphosphate; MAP3K, mitogen-activated
  protein kinase kinase kinase; MAP2K, mitogen-activated protein kinase kinase; MEKK2,
  mitogen-activated protein kinase kinase kinase 2; MLK3, mixed-lineage kinase 3;
  MEK, mitogen-activated protein kinase kinase; CREB, cAMP response element-binding
  protein; RSK2, p90 ribosomal S6 kinase; Runx2, Runt-related transcription factor
  2.
papertitle: The Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase
  Pathway in Osteoblasts.
reftext: Matthew B. Greenblatt, et al. J Bone Metab. 2022 Feb;29(1):1-15.
year: '2022'
doi: 10.11005/jbm.2022.29.1.1
journal_title: Journal of Bone Metabolism
journal_nlm_ta: J Bone Metab
publisher_name: The Korean Society for Bone and Mineral Research
keywords: Bone and bones | Extracellular signal-regulated MAP kinases | Mitogen-activated
  protein kinases | Osteoblasts
automl_pathway: 0.9434795
figid_alias: PMC8948490__F1
figtype: Figure
redirect_from: /figures/PMC8948490__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8948490__jbm-2022-29-1-1f1.html
  '@type': Dataset
  description: A diagram of extracellular signal-regulated kinase (ERK) mitogen-activated
    protein kinase (MAPK) signaling pathways in osteoblasts. Noteworthy inhibitors,
    including both clinical drugs and tool compounds, are indicated. NF1, neurofibromatosis
    type 1; GDP, guanosine diphosphate; GTP, guanosine triphosphate; MAP3K, mitogen-activated
    protein kinase kinase kinase; MAP2K, mitogen-activated protein kinase kinase;
    MEKK2, mitogen-activated protein kinase kinase kinase 2; MLK3, mixed-lineage kinase
    3; MEK, mitogen-activated protein kinase kinase; CREB, cAMP response element-binding
    protein; RSK2, p90 ribosomal S6 kinase; Runx2, Runt-related transcription factor
    2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Map3k2
  - Nf1
  - Creb1
  - Map2k1
  - Rps6ka3
  - Mapk3
  - Zhx2
  - Runx2
  - Akt1
  - Rho
  - Rhod
  - Ea2
  - Cdc42
  - Kcnk7
  - Map3k11
  - Map2k3
  - Map2k6
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - MAP3K1
  - MAP3K2
  - MAP3K3
  - MAP3K4
  - MAP3K5
  - MAP3K6
  - MAP3K7
  - MAP3K8
  - MAP3K9
  - MAP3K10
  - MAP3K11
  - MAP3K12
  - MAP3K13
  - MAP3K14
  - MAP3K15
  - MAP3K19
  - MAP3K20
  - MAP3K21
  - ARAF
  - BRAF
  - RAF1
  - TAOK1
  - TAOK2
  - TAOK3
  - MAP2K3
  - MAP2K4
  - MAP2K5
  - MAP2K6
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - KRAS
  - HRAS
  - NRAS
  - NF1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - RPS6KA3
  - MTG1
  - ZHX2
  - RUNX2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - CDC42
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - rab1ab
  - nf1a
  - map2k1
  - mapk3
  - kita
  - ngfra
  - rho
  - rnd2
  - cdc42
  - cdc42l
  - map2k6
  - mapk14a
  - MKP-4
  - p38b
  - rl
  - Ras64B
  - Ras85D
  - CrebB
  - CrebA
  - S6kII
  - Raf
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Bx
  - Rho1
  - Lcp65Ab1
  - lic
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
---
